NCT05694650 Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
| NCT ID | NCT05694650 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-10-12 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2022-10-12 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this qualitative research study is to assess the knowledge, attitudes and beliefs of cancer care providers, patients with cancer and caregivers regarding hospital care at home. We aim to conduct qualitative interviews to inform implementation of future on oncology hospital care at home programs
Eligibility Criteria
Inclusion Criteria: 1. Cancer Care Providers * Cancer care providers of any specialty, including but not limited to oncologists, surgeons, hospitalists, emergency medicine physicians, nurses (including nurse practitioners), physician assistants, and any other member of the cancer care team (eg social workers or physical therapists) * Employed by the University of Texas MD Anderson Cancer Center 2. Patients * Adults ages 18 and over * Currently undergoing or completed cancer treatment within the last 5 years at MD Anderson * Able to speak and read in English 3. Caregivers * Adults ages 18 and over * Self-identifies as a caregiver of an individual over 18 who is currently undergoing cancer treatment or completed cancer treatment within the last 5 years at MD Anderson * Able to speak and read in English Exclusion: None
Contact & Investigator
Josiah Halm, MD, MPH
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05694650 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05694650 currently recruiting?
Yes, NCT05694650 is actively recruiting participants. Contact the research team at jhalm@mdanderson.org for enrollment information.
Where is the NCT05694650 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05694650 clinical trial?
NCT05694650 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Josiah Halm, MD, MPH at M.D. Anderson Cancer Center. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.